HETERO

Production of anti-retroviral and anti-cancer pharmaceuticals in Russia.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About HETERO

HETERO is a company. HETERO offers products and services including Anti-Retroviral Drugs and Anti-Cancer Drugs.

Operational Areas
Healthcare → Healthcare Products & Supplies → →
Healthcare → Pharmaceuticals & Therapeutics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of HETERO

HETERO offers a comprehensive portfolio of products and services, including Anti-Retroviral Drugs and Anti-Cancer Drugs.

Primary

Anti-retroviral drugs are manufactured for affordable treatment of viral conditions

Various anti-cancer medications are produced in forms such as tablets and infusions for effective disease management

Funding Insights of HETERO

Investments & Acquisitions by HETERO

Investments

Financial Statements - HETERO

Hetero Comparisons

+
Add Comparison
Available on Premium

Competitors of HETERO

Latest news on Hetero

Frequently Asked Questions about HETERO

HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ООО МАКИЗ-ФАРМА in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.

HETERO offers Anti-Retroviral Drugs and Anti-Cancer Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available